In the May issue of CAP TODAY, Minetta Liu, M.D., of the Department of Medical Oncology and the Department of Laboratory Medicine and Pathology at Mayo Clinic discusses the use of circulating tumor cell (CTC) enumeration in her clinical practice.
This is the story of two perfectly harmless genes. By themselves, PAX3 and MAML3 don’t cause any problems. However, when they combine during an abnormal but recurring chromosomal mismatch, they can be dangerous. The result is a chimera — a gene that is half of each — and that causes biphenotypic sinonasal sarcoma.
View our featured oncology offerings, browse Mayo Clinic presentation topics and times, and if you are attending the show in Chicago, visit us at booth #2054.
- Molecular Diagnosis Of Bone And Soft Tissue Tumors [Communiqué]
- Mayo Clinic and Mayo Medical Laboratories Launch 50-gene Cancer Panel Test [News]
- Next Generation Sequencing Panel for Solid Tumor Cancers [A Test in Focus]
- Genomic Testing for Breast Cancer Susceptibility Genes Helps Determine Enhanced Screening and Prevention Strategies
- Tissue Testing During Breast Cancer Lumpectomies Prevents Need for Reoperation 96 Percent of Time